AVE Science & Technology Co

AVE Science & Technology Co Net Debt/FCF

Net Debt to Free Cash Flow Ratio of AVE Science & Technology Co (688067.SS) as of Oct 17, 2026.

Net Debt/FCF

-

Last updated:

Net Debt to Free Cash Flow Ratio of AVE Science & Technology Co is 2026 - . Net Debt to Free Cash Flow Ratio of AVE Science & Technology Co was 2025 -3.84 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co Ltd, based in Changsha, China, operates in the Health Care sector, specializing in clinical testing and analysis instruments. The company develops, produces, and sells a range of diagnostic equipment, including urine and stool analyzers, body fluid analyzers, and reproductive tract secretion analyzers, alongside related reagents and consumables. With 545 employees, it serves domestic and international markets, focusing on medical and health institutions for diagnostic solutions. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's AVE Science & Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co